Foresee Home
DeviceHome Monitoring
NCT Number: NCT00963339
The purpose of this study is to evaluate the usability of the Foresee Home device with intermediate AMD patients.
Looking for future studies?
Notify Me50 year and older
All sexes
Observational
The AMD usability study is a prospective, longitudinal, multi-center, observational study of patients diagnosed with intermediate (dry) AMD who have been asked by their doctor to use the ForeseeHomeTM device to record the natural progression of their AMD, including conversion from the dry to wet stage.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Home Monitoring
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 month
Notal Vision Ltd.
Industry
Acronym: AMD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02725762
Age Related Macular Degeneration, Eye Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT03076697
Age Related Macular Degeneration, Cardiovascular Diseases
View Trial DetailsNCT07318428
Age Related Macular Degeneration, Cardiovascular Diseases
Busan, South Korea
View Trial DetailsNCT07424235
AMD, Age Related Macular Degeneration
View Trial Details